|
DIS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.45069999638537E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.26650000001438E-06 |
| Normal-vs-Stage2 |
2.16309999999664E-05 |
| Normal-vs-Stage3 |
4.50880000002485E-07 |
| Normal-vs-Stage4 |
5.00069999964659E-07 |
| Stage1-vs-Stage2 |
3.078600E-01 |
| Stage1-vs-Stage3 |
2.043000E-01 |
| Stage1-vs-Stage4 |
1.822830E-01 |
| Stage2-vs-Stage3 |
9.412600E-01 |
| Stage2-vs-Stage4 |
8.313600E-01 |
| Stage3-vs-Stage4 |
7.481600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.03159999723601E-08 |
| Normal-vs-AfricanAmerican |
1.021390E-01 |
| Normal-vs-Asian |
4.48029999999822E-05 |
| Caucasian-vs-AfricanAmerican |
6.836000E-02 |
| Caucasian-vs-Asian |
9.079200E-01 |
| AfricanAmerican-vs-Asian |
1.113190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33049999801105E-08 |
| Normal-vs-Female |
6.22489999990705E-07 |
| Male-vs-Female |
1.671370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.94369999999755E-05 |
| Normal-vs-Age(41-60Yrs) |
3.07949999944768E-07 |
| Normal-vs-Age(61-80Yrs) |
5.52340000403717E-08 |
| Normal-vs-Age(81-100Yrs) |
1.147610E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.919010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.416200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.680600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.626400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.600200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.663600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.384790E-01 |
| Classical-VS-Follicular |
4.855500E-02 |
| Classical-VS-Other |
1.375000E-01 |
| Classical-VS-Normal |
1.53167999999981E-05 |
| Tall-VS-Follicular |
8.938600E-01 |
| Tall-VS-Other |
4.359800E-01 |
| Tall-VS-Normal |
4.31040000000715E-05 |
| Follicular-VS-Other |
4.836200E-01 |
| Follicular-VS-Normal |
2.10160000002624E-06 |
| Other-VS-Normal |
2.435200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.04039999632755E-08 |
| Normal-vs-N1 |
2.43310000003216E-06 |
| N0-vs-N1 |
7.581400E-01 |
|
|
